– USA, MA – XebiaLabs, a leading provider of software delivery automation solutions for DevOps and Continuous Delivery, today announced that its Board of Directors has appointed Derek Langone as Chief Executive Officer and member of the Board of Directors effective immediately. Most recently serving as Co-founder of Shuttersong Inc., Langone is a veteran of the software industry who has held senior leadership positions at a number of high growth software companies over an impressive 20-year career. Based in Boston, Langone will bring his expertise in sales to lead XebiaLabs’ continued growth in a rapidly expanding industry.
“As software continues to become more pervasive, delivering the right software at the right time, and in the right way is a critical competitive capability, but most organizations are flat on their feet,” Langone said. “XebiaLabs has an elegant solution to the challenges and pressures of continuously delivering great software. I am excited to lead the company and build on the already impressive momentum.”
Langone served as CEO and COO of SmartBear Software, a leader in software quality assurance solutions, helping the business grow from $2.5MM to over $40MM in revenues in five years, and executing four acquisitions. Langone also served as Executive Vice President of Global Sales for Telerik, a mobile applications development company recently acquired by Progress Software. Earlier in his career, Langone held senior sales executive roles at Quest Software and Imceda.
Today, a company’s capacity to capture new markets, provide new services or engage customers in new ways is often dependent on its IT department’s ability to create and release new software. However, the pace of software development is no longer an annual or semi-annual exercise, but rather a continuous flow of new iterations and adjustments to meet market needs in real-time. In its annual report on the state of software, XebiaLabs reports that although organizations expect to offer a 20 percent increase in applications this year, they will have no increase in workforce. At the same time, the software release process remains a manual and error-ridden exercise for which most organizations do not have the proper tools in place to manage.
XebiaLabs enables organizations across all industries to develop software in a continuous and automated delivery model through three core products. XL Release lets organizations manage, control and visualize Continuous Delivery application development pipelines. XL Deploy enables IT to automate application deployments so releases occur in a repeatable, standard and efficient way. XL Test is the first test management solution that allows development teams to consolidate, centrally control and report on all tests used to measure the quality of a new application.
“We are thrilled to have Derek leading XebiaLabs as the market opens up for our solutions,” said Daan Teunissen, chairman of XebiaLabs’ Board of Directors. “He is a proven leader with growth-stage success, direct experience in our markets, and the capacity to bring people together. On behalf of the board and employees of XebiaLabs, we welcome him onboard.”
With the appointment of Derek Langone, XebiaLabs also announced that founding CEO Coert Baart will assume the new role of Co-Founder and Senior Vice President EMEA/APAC, where he will focus on building XebiaLabs’ European business and continue to serve as a senior advisor to the Board of Directors.
XebiaLabs is the technology leader for automation software for DevOps and Continuous Delivery. We focus on helping companies accelerate the delivery of new software in the most efficient manner. Our products are simple to use, quick to implement, and provide robust enterprise technology. Founded in 2008 and headquartered in Boston, XebiaLabs has a worldwide network of sales offices and partners.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.